The three-year UNITED 2.0 initiative will use advanced DNA testing and AI to give doctors a more complete picture of a patient’s cancer and help match treatments more precisely.

Quarter Horse Owner Banned 10 Years, Fined $20,000 Over ‘Extensive Medication Record’ OBS March Sale matched record with seven horses selling for over $1 million. Total gross reached a record $72,050, ...

Single-cell RNA sequencing of endometrial samples across the menstrual cycle identified key cell types and gene signatures ...

Ocala Breeders' Sales March 2-Year-Olds in Training Sale concludes with a record gross of $72,050,000, including private ...

"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...

RNA reveals plants' real-time biological response to stress, which occurs long before conventional tools detect problems, ...

The following segment was excerpted from the Harbor Health Care ETF Q4 2025 Commentary.During the fourth quarter, the Harbor Health Care ETF ...

The startup is developing AI foundation models trained on DNA rather than text or code, applying deep learning techniques to ...